FESILI1

PUSI # Igoa Oloa Fa'amatalaga
CPD100608 ASK1-Inhibitor-10 ASK1 Inhibitor 10 o se fa'agata fa'aola fa'aolaola ole apoptosis signal-regulating kinase 1 (ASK1). E filifilia mo ASK1 i luga ole ASK2 faʻapea foi MEKK1, TAK-1, IKKβ, ERK1, JNK1, p38α, GSK3β, PKCθ, ma B-RAF. E taofia ai le faateleina o le streptozotocin i le JNK ma le p38 phosphorylation i le INS-1 pancreatic β sela i se tulaga faʻalagolago.
CPD100607 K811 K811 ose ASK1-specific inhibitor e faʻaumiina le ola i se faʻataʻitaʻiga o le isumu o le amyotrophic lateral sclerosis. O le K811 na puipuia lelei le fa'atuputeleina o sela i laina sela e maualuga le fa'aaliga ASK1 ma i le HER2-ova fa'amatalaga GC sela. Togafitiga fa'atasi ma K811 fa'aitiitia le lapopo'a o tuma xenograft e ala i le fa'alaloina o fa'ailoga fa'ateleina.
CPD100606 K812 K812 ose ASK1-specific inhibitor na maua e faʻaumi ai le ola i se faʻataʻitaʻiga o le isumu o le amyotrophic lateral sclerosis.
CPD100605 MSC-2032964A MSC 2032964A ose malosi ma filifili ASK1 inhibitor (IC50 = 93 nM). E poloka ai le LPS-induced ASK1 ma le p38 phosphorylation i astrocytes isumu aganuʻu ma taofia le neuroinflammation i se faʻataʻitaʻiga EAE kiore. MSC 2032964A o lo'o maua fa'aola fa'alaua'itele ma o'o i le fai'ai.
CPD100604 Selonsertib Selonsertib, lea e taʻua foi o le GS-4997, o se iniseti faʻaola e mafai ona faʻaogaina o le apoptosis signal-regulating kinase 1 (ASK1), faʻatasi ai ma gaioiga faʻamaʻi, antineoplastic ma anti-fibrotic. GS-4997 taulaʻi ma fusifusia i le catalytic kinase domain o le ASK1 i se ATP-faʻatauva, ma puipuia ai lona phosphorylation ma le faʻagaoioia. GS-4997 e taofia ai le gaosiga o cytokines inflammatory, lalo-faʻatonutonu le faʻaaliga o kenera e aʻafia i fibrosis, taofiofia le tele o apoptosis ma faʻalavelaveina le faʻalauteleina o le telefoni.
;

Faafesootai matou

Su'esu'ega

Tala Fou

  • Top 7 Fa'asologa i Su'esu'ega Fa'afoma'i I le 2018

    Top 7 Fa'asologa i Su'esu'ega Fa'afoma'i I...

    O le i ai i lalo o le faʻateleina o le malosi e tauva ai i se luʻitau o le tamaoaiga ma tekinolosi, e tatau i kamupani vailaʻau ma biotech ona faʻaauau pea ona faʻafouina a latou polokalame R&D ina ia tumau i luma ...

  • ARS-1620: O se fa'atosina fou fa'amoemoeina mo KRAS-mutant kanesa

    ARS-1620: O se fa'ailo fou fou mo K...

    E tusa ai ma se suʻesuʻega na lomia i totonu Cell, ua atiaʻe e le au suʻesuʻe se inhibitor faʻapitoa mo KRASG12C ua taʻua o le ARS-1602 lea na faʻaosoina ai le faʻatupuina o le tumo i isumu. "O lenei suʻesuʻega e tuʻuina atu i vivo faʻamaoniga e mafai ona avea mutant KRAS ...

  • E maua e le AstraZeneca le faʻamalosia o tulafono mo vailaʻau oncology

    Ua maua e le AstraZeneca le faamalosia o tulafono mo...

    Na maua e le AstraZeneca se faʻaleleia faʻalua mo lana oncology portfolio i le Aso Lua, ina ua uma ona talia e le US ma Europa tulafono faʻatonutonu talosaga mo ana vailaʻau, o le laasaga muamua lea i le mauaina o le faʻatagaina mo nei vailaʻau. ...

WhatsApp Online Chat!